PS.

Transitional Drugs 7

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)contractFind a Tender ↗Ref ocds-h6vhtk-067da4Procurement Act 2023SME suitablepending

Estimated value

—

Awarded value

£16.8m

Awarded 03 Jun 2026

Suppliers

10

Lots

1

1 awarded

Published

05 Jun 2026

Description

Supply of Transitional Drugs 7

Scope

Reference
PHA-FTS-62154
Commercial tool
Standalone contract
Contract dates
30 Jun 2026 to 30 Jun 2028
Possible extension to 30 Jun 2030

Extension option of up to 2 years available.

CPV classifications
33600000
Contract locations
Wales, United Kingdom
Particular suitability
Small and medium-sized enterprises (SME)

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
Product Quality/AcceptabilityPass/Failquality1.00%
Financial (Overall Cost of Contract)Weighting:85cost2.00%
Environmental/Social Value/Community BenefitsWeighting :15quality3.00%

Participation

Conditions suppliers must meet to bid.

As per the tender documents.

Submission & procedure

Procedure
Open procedure

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£16.8m

Award date

03 Jun 2026

Contract start

30 Jun 2026

Contract end

30 Jun 2028

Awarded to
AL
Amgen Ltd
FK
Fresenius Kabi Ltd
CH
Celltrion Healthcare
HP
Hikma Pharmaceuticals International Ltd
VP
Vifor Pharma UK Ltd
RP
Roche Products Ltd
GR
Gedeon Richter
NP
Novartis Pharmaceuticals UK Ltd
MP
Mercury Pharmaceuticals Ltd
CP
Celix Pharma